Related references
Note: Only part of the references are listed.Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?
Dilek Unal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
Joanna Szkandera et al.
PLOS ONE (2013)
An immunological insight into the origins of pre-eclampsia
Estibalitz Laresgoiti-Servitje et al.
HUMAN REPRODUCTION UPDATE (2010)
Increased Neutrophil Numbers Account for Leukocytosis in Women with Preeclampsia
Bernard J. Canzoneri et al.
AMERICAN JOURNAL OF PERINATOLOGY (2009)
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
HanByoul Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Adverse perinatal outcomes and risk factors for Preeclampsia in women with chronic hypertension - A prospective study
Lucy C. Chappell et al.
HYPERTENSION (2008)
Elevated maternal IL-16 levels, enhanced IL-16 expressions in endothelium and leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia
Yang Gu et al.
JOURNAL OF IMMUNOLOGY (2008)
Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma
I Hromadnikova et al.
FETAL DIAGNOSIS AND THERAPY (2005)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Share Paper
